UBS O'Connor’s Magellan Health Services, Inc. MGLN Stock Holding History

UBS O'Connor’s Portfolio MGLN Stock Details MGLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,743,181	Closed	-$165M	–	885
2021 Q4	$165M	Sell	1,743,181 -716,135	-29%	-$67.8M	1.59%	9
2021 Q3	$233M	Buy	2,459,316 +2,083,074	+554%	+$197M	1.83%	10
2021 Q2	$35.4M	Buy	376,242 +89,571	+31%	+$8.44M	0.32%	28
2021 Q1	$26.7M	Buy	+286,671	New	+$26.9M	0.39%	29

UBS O'Connor's MGLN Position: Q1 2022 in Review

UBS O'Connor sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 1,743,181 shares — an estimated $165M sold.

UBS O'Connor first reported a position in MGLN in Q1 2021 and held it in 4 quarters. The position peaked at $233M in Q3 2021. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.

UBS O'Connor reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
UBS O'Connor sold 1,743,181 Magellan Health Services, Inc. shares in Q1 2022, an estimated $165M.
UBS O'Connor first reported a position in Magellan Health Services, Inc. in Q1 2021 and held it in 4 quarters.
UBS O'Connor's Magellan Health Services, Inc. position peaked at $233M in Q3 2021.
0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.